Indrayani Biotech (BSE 526445)₹7.78−0.89%Other Agricultural Products
At the end of the Jun 2026 quarter, Indrayani Biotech's shareholders were: promoters 32.89%, DIIs 3.15%, public 63.96%. Promoter holding is down 0.34 percentage points from 33.23% a quarter earlier. It had 25,802 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 44.81% | 33.60% | 33.54% | 33.45% | 33.37% | 33.25% | 33.25% | 33.25% | 33.23% | 33.23% | 33.23% | 32.89% |
| DIIs | 13.15% | 7.62% | 6.79% | 4.10% | 5.63% | 5.29% | 3.69% | 3.13% | 3.15% | 3.15% | 3.15% | 3.15% |
| Public | 42.04% | 58.78% | 59.67% | 62.45% | 61.00% | 61.46% | 63.06% | 63.62% | 63.62% | 63.62% | 63.62% | 63.96% |
| Number of shareholders | 22,582 | 23,026 | 23,949 | 24,123 | 24,410 | 25,245 | 25,117 | 25,695 | 25,677 | 25,556 | 25,500 | 25,802 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| G Swaminathan | Promoter | 9.02% | 0.00 |
| Jayaseelan Singaravelu | Public | 8.10% | −0.68 |
| Sayee Sundar Kasiraman | Promoter | 5.77% | 0.00 |
| S Indirakumar | Promoter | 4.59% | 0.00 |
| I Umasundari | Promoter | 4.58% | 0.00 |
| Sonal Lohia | Public | 3.91% | 0.00 |
| Ajitkumar Chimanbhai Patel | Public | 2.88% | +0.04 |
| M Ramesh | Promoter | 2.32% | 0.00 |
| Jothi Ramesh | Promoter | 2.30% | 0.00 |
| Lrsd Securities Pvt Ltd | DII | 2.05% | 0.00 |
| S Prakash | Public | 1.56% | −0.11 |
| Thirumeni Thiruselvaraja | Promoter | 1.55% | −0.17 |
| S I Dinesh Kumar | Promoter | 1.53% | 0.00 |
| Karuppannan A | Public | 1.29% | 0.00 |
| V Agathiyan | Promoter | 1.15% | −0.17 |
| Mahendra Girdharilal | Public | 1.09% | New |
| Rajasthan Global Securities Private Limited | DII | 1.07% | 0.00 |
| Priyadarshini | Public | 1.04% | −0.09 |
| Malarvannan Subashini | Public | Exited | — |
Promoters held 32.89% of Indrayani Biotech at the end of the Jun 2026 quarter, down 0.36 percentage points from 33.25% a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held no reported stake and domestic institutions (DIIs) held 3.15% (unchanged at 3.15% a quarter earlier).
Indrayani Biotech had 25,802 shareholders at the end of the Jun 2026 quarter, against 25,695 a year earlier.
Jayaseelan Singaravelu (Public) held 8.10% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.